Endologix Reports Results for the Fourth Quarter and Full Year 2016
February 22, 2017 16:05 ET
|
Endologix
IRVINE, Calif., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three...
Endologix Completes Patient Enrollment in the Ovation® LUCY Study
February 14, 2017 16:01 ET
|
Endologix
IRVINE, Calif., Feb. 14, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient...
Endologix to Report Fourth Quarter and Full Year 2016 Financial Results on February 22, 2017
February 07, 2017 09:00 ET
|
Endologix
IRVINE, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today details relating to the release...
Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board
February 06, 2017 09:00 ET
|
Endologix
John McDermott to Continue as Chief Executive Officer IRVINE, Calif., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic...
Endologix to Present at Leerink Partners 6th Annual Global Healthcare Conference
February 03, 2017 16:05 ET
|
Endologix
IRVINE, Calif., Feb. 03, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that Vaseem Mahboob, Chief...
Endologix Announces Reinstatement of CE Mark for AFX® and AFX2 Endovascular AAA Systems
January 25, 2017 12:00 ET
|
Endologix
IRVINE, Calif., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced that it received notice from...
Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium
January 25, 2017 09:00 ET
|
Endologix
IRVINE, Calif., Jan. 25, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the presentation of positive...
Endologix Resumes Shipments of All Sizes of AFX®2 Endovascular AAA Systems
January 17, 2017 10:28 ET
|
Endologix
IRVINE, Calif., Jan. 17, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced that the company has resumed...
Endologix to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 03, 2017 16:01 ET
|
Endologix
IRVINE, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief...
Endologix Provides Physicians with Updated Information about the AFX® Endovascular AAA System
December 30, 2016 08:00 ET
|
Endologix
IRVINE, Calif., Dec. 30, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, today issued a letter to physicians with...